Neuro-COVID is a serious complication of SARS-CoV-2 infections and can determine the long-term outcome of COVID-19
Date
2022ISSN
1680 5348
Author
Metadata
Show full item recordAbstract
[EXTRACTO]. We read with interest the review article by Matar-Khalil about neuro-COVID. The author concluded that the exact mechanisms of brain damage from SARS-CoV-2 have not yet been elucidated, and that it is necessary to continue with longitudinal and international research, including studies that include epidemiological, clinical and diagnostic variables to define them and establish their implication in mental health, as well as its long-term consequences. The study is appealing but raises concerns that should be discussed. A response to this letter is available at: https://doi.org/10.26633/RPSP. 2022.192
Pages
191
Subject
Citation
Finsterer J. Neuro-COVID is a serious com- plication of SARS-CoV-2 infections and can determine the long-term outcome of COVID-19. Rev Panam Salud Publica. 2022;46:e191. https://doi.org/10.26633/RPSP.2022.191
Collections
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-NoDerivs 3.0 IGO
Related items
Showing items related by title, author, creator and subject.
-
Organização Pan-Americana da Saúde; Representação da OPAS/OMS no Brasil (OPASBrazilBrasilia, D.F., 2022)Este documento tem como objetivo descrever um conjunto mínimo de atividades de vigilância recomendadas em nível nacional para detectar e monitorar a prevalência relativa de variantes do SARS-CoV-2 e delinear um conjunto ...
-
Pan American Health Organization; Health Emergencies (PHE) (PAHOUnited StatesWashington, D.C., 2021)This report documents PAHO’s efforts in the first six months of 2021, period in which the Organization continued responding to emerging needs in the Americas Region to detect, track, treat and slow the spread of COVID-19; ...
-
Rodrigues Campos, Karoline; Tavares Sacchi, Cláudio; Abbud, Adriano; Caterino-de-Araujo, Adele (2021)[ABSTRACT]. COVID-19 vaccination began in São Paulo, Brazil in January 2021, first targeting healthcare workers (HCWs) and the elderly, using the CoronaVac vaccine (Sinovac/Butantan) and subsequently the Oxford/AstraZeneca ...